Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients on Intensive Insulin Treatment

被引：0
|
作者：
Cai, Xiaoling
Luo, Yingying
Han, Xueyao
Ji, Linong
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2236-PO
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
  • [31] Psychometric Analysis Regarding the Barriers to Providing Effective Insulin Treatment in Type 2 Diabetic Patients
    Ku, Eu Jeong
    Lee, Dong-Hwa
    Jeon, Hyun Jeong
    Park, Frank
    Oh, Tae Keun
    DIABETES THERAPY, 2021, 12 (01) : 159 - 170
  • [32] Psychometric Analysis Regarding the Barriers to Providing Effective Insulin Treatment in Type 2 Diabetic Patients
    Eu Jeong Ku
    Dong-Hwa Lee
    Hyun Jeong Jeon
    Frank Park
    Tae Keun Oh
    Diabetes Therapy, 2021, 12 : 159 - 170
  • [33] Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment
    M. Ozbek
    M. Erdogan
    M. Karadeniz
    S. Cetinkalp
    A. G. Ozgen
    F. Saygili
    C. Yilmaz
    M. Tuzun
    Acta Diabetologica, 2006, 43 : 148 - 151
  • [34] Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment
    Ozbek, M.
    Erdogan, M.
    Karadeniz, M.
    Cetinkalp, S.
    Ozgen, A. G.
    Saygili, F.
    Yimaz, C.
    Tuzun, M.
    ACTA DIABETOLOGICA, 2006, 43 (04) : 148 - 151
  • [35] Comparison between lispro insulin and regular insulin in continuous subcutaneous insulin infusion treatment in Korea type 2 diabetic patients
    Choi, SB
    Kim, SD
    Park, SM
    DIABETES, 2000, 49 : A355 - A355
  • [36] Intensive insulin therapy in patients with type 2 diabetes
    Bering, Balpreet
    Devendra, Devasenan
    LANCET, 2008, 372 (9640): : 716 - 717
  • [37] The significance of tumor necrosis factor-α in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
    Chen, Haibing
    Ren, An
    Hu, Shilian
    Mo, Weilin
    Xin, Xuenong
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 75 (03) : 327 - 332
  • [38] An alternative treatment with glibomet in obese Type 2 diabetic patients on insulin therapy
    Pankiv, VI
    DIABETOLOGIA, 2004, 47 : A252 - A252
  • [39] Towards earlier and more aggressive insulin treatment in type 2 diabetic patients
    Passa, P
    DIABETES & METABOLISM, 2001, 27 (05) : S5 - S6
  • [40] Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients
    Fischer, S
    Patzak, A
    Rietzsch, H
    Schwanebeck, U
    Köhler, C
    Wildbrett, J
    Fuecker, K
    Temelkova-Kurktschiev, T
    Hanefeld, M
    DIABETES OBESITY & METABOLISM, 2003, 5 (01): : 38 - 44
12345